Patent case...let's take a look from Dr. Reddy's point of view
Let's assume that we are not AMRN investors, but owners of Dr. Reddy's and of other dietary supplement firms. I have read that fish-oil is the largest selling dietary supplement in the world (not sure if that is correct).
If you are a dietary supplement firm selling fish-oil, wouldn't you dig in your heels and never settle with the hope on the small chance that you may prevail at trial? I would assume you do not want to give up market share of your largest selling item. The settlement that AMRN may offer might be a pittance of what you would lose if sales dramatically decline.
I would also assume that the upcoming AMRN's direct-to-consumer advertisements will strongly emphasize the limitations of dietary supplement fish oil as compared to prescribed icosapent-ethyl Vascepa.
For all we know, Dr. Reddy's may have entered into this litigation with the attitude that they will never settle for anything less than an outright decision regarding the patent infringement.
Things seem in AMRN's favor, but who knows how the trial judge will actually respond after hearing arguments?
Cheers!
Flubber
PS. Didn't mean to respond to rosemountbombers comment. should have been NEW MESSAGE
News 
Market Data 
Discover 
